Back to search

Lack of change in striatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in man

Data up to Jan 2025

Published1990
Citations26
References32

Total Citations Per Year

Abstract

References (32)

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

1951 • 319,299 citations

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1970 • 253,849 citations

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

1979 • 54,907 citations

Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis

1983 • 4,822 citations

Multiple receptors for dopamine

1979 • 3,739 citations

Postsynaptic Supersensitivity after 6‐Hydroxy‐dopamine Induced Degeneration of the Nigro‐striatal Dopamine System

1971 • 1,922 citations

Dopamine (3-hydroxytyramine) and brain function.

1966 • 1,401 citations

DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization

1984 • 652 citations

PROTEIN KINASES IN THE BRAIN

1985 • 559 citations

A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions

1983 • 342 citations

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset

1984 • 324 citations

DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Regional and cellular distribution in the rat brain

1984 • 303 citations

Direct phosphorylation of brain tyrosine hydroxylase by cyclic AMP-dependent protein kinase: mechanism of enzyme activation.

1978 • 286 citations

DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein: regional, tissue, and phylogenetic distribution

1986 • 229 citations

Progressive Supranuclear Palsy

2005 • 218 citations

Neuronal Phosphoproteins: Physiological and Clinical Implications

1984 • 216 citations

Dopaminergic and cholinergic lesions in progressive supranuclear palsy

1985 • 213 citations

DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. II. Purification and characterization of the phosphoprotein from bovine caudate nucleus

1984 • 209 citations

Independent in vitro regulation by the D-2 dopamine receptor of dopamine-stimulated efflux of cyclic AMP and K+-stimulated release of acetylcholine from rat neostriatum

1982 • 184 citations

Determination of 5-hydroxytryptophan, serotonin and 5-hydroxyindoleacetic acid in rat and human brain and biological fluids by reversed-phase high-performance liquid chromatography with electrochemical detection

1981 • 102 citations

D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy

1988 • 95 citations

Progressive supranuclear Palsy

1971 • 93 citations

BRAIN GLUTAMATE DECARBOXYLASE IN PARKINSON'S DISEASE WITH PARTICULAR REFERENCE TO A PREMORTEM SEVERITY INDEX

1985 • 76 citations

Micro topography of Tyrosine Hydroxylase, Glutamic Acid Decarboxylase, and Choline Acetyltransferase in the Substantia Nigra and Ventral Tegmental Area of Control and Parkinsonian Brains

1981 • 68 citations

POST MORTEM STABILITY AND STORAGE IN THE COLD OF BRAIN ENZYMES

1979 • 63 citations

Striatal phosphoproteins in Parkinson disease and progressive supranuclear palsy.

1989 • 59 citations

Dopamine D‐1 Receptor and Cyclic AMP‐Dependent Phosphorylation in Parkinson's Disease

1987 • 55 citations

Postmortem stability of norepinephrine, dopamine, and serotonin in rat brain

1977 • 54 citations

Post-mortal changes of dopamine and homovanillic acid levels in rat striatum as measured by mass gragmentography

1974 • 42 citations

Selective decrease of large neurons in the neostriatum in progressive supranuclear palsy

1988 • 35 citations

Biochemical changes accompanying unilateral 6-hydroxydopamine lesions in the rat substantia nigra

1978 • 28 citations

Pitfalls in Membrane Binding Sites Studies in Post-Mortem Human Brain

1987 • 16 citations

Cited By (0)

Loading...
Lack of change in striatal DARPP-32 levels following nigrostriatal dopaminergic lesions… (1990) – Brain Research | Metascience Observatory Explorer